Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kite Pharma Inc.

Division of Gilead Sciences Inc.

Latest From Kite Pharma Inc.

Gene Therapy Manufacturing Remains Large Hurdle For Development, US FDA's CBER Director Says

Scale-up in particular is a challenge and FDA wants to help lower the barrier, CBER Director Peter Marks tells rare disease conference.

Regenerative Medicine Research and Development Strategies

R&D Head Sean Harper On Amgen's Long-Term Investment View

Amgen is validating targets through the deCODE Genetics investment it made five years and moving drugs into the clinic. It's one of multiple technologies – along with its BiTE and oncolytic virus platforms – that R&D head Sean Harper said is starting to bear fruit for the company.

Business Strategies Research and Development Strategies

PRIME Dry Spell Ends As EMA Takes On Eye Disease Gene Therapy

The first designation of 2018 under the European Medicines Agency’s PRIME scheme has gone to an advanced therapy for patients with the severe eye disorder, achromatopsia. In the meantime, most PRIME applications are still getting rejected.

Review Pathway Research & Development

In Vivo's Deals Of The Month, February 2018

In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)
Deals Market Intelligence
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Gilead Sciences Inc.
  • Senior Management
  • Arie Belldegrun, MD, Pres. & CEO
    Paul Jenkinson, CFO
    David Chang, MD, PhD, EVP, R&D & CMO
    Cynthia M Butitta, COO
    Shawn Tomasello, Chief Commercial Officer
  • Contact Info
  • Kite Pharma Inc.
    Phone: (310) 824-9999
    2225 Colorado Ave.
    Santa Monica, CA 90404